🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to the authors of this wonderful publication in CKJ and nice discussion of novel potential coding of kidney biopsies as research does not stand still ERA Registry

Excited to share out latest work in CKJ! academic.oup.com/ckj/advance-ar… We present first data on the FCGG registry, which covers all native kidney biopsies performed in Flanders, Belgium, since 2017. Check out the YNP of ERA page for a quick Q&A on the study findings!

Treatment of acute kidney injury in cancer patients | Clinical Kidney Journal | ⁦CKJ⁩ academic.oup.com/ckj/article/15…

Happy to announce my candidacy for the ERA Council – remember to use your vote and please do motivate your network to do the same! era-online.org/en/era-general…

Improving cancer care for patients with chronic kidney disease: the need for changes in clinical trials kireports.org/article/S2468-…

Improving cancer care for patients with chronic kidney disease: the need for changes in clinical trials ⁦KIReports⁩ kireports.org/article/S2468-…

🆕“Prevention is better than cure”: warning for comedications in patients receiving immune check-point inhibitors to avoid AKI 📖bit.ly/3n8N9fW 👉ICIs may be a ‘second hit’ that precipitates AKI caused by a concomitant drug ben sprangers CHU de Toulouse - compte inactif @IUCTOncopoleICR

A sad day in the USA

💡Read Anushree Shirali and Ben Sprangers's review of Cancer Drug Dosing in Chronic Kidney Disease and Dialysis in the current issue of Advances in Chronic Kidney Disease @ackdonline! 👇🏻 ackdjournal.org/article/S1548-…

1/🥁YNP PAPER ALERT! Research of Dries Deleersnijder and colleagues on clinicopathological characteristics and disease chronicity in native kidney bx in Flanders was published by CKJ. Tweets were prepared by Sourabh Sharma. academic.oup.com/ckj/advance-ar… Maria Jose Soler ERA - European Renal Association

pubmed.ncbi.nlm.nih.gov/36168055/. Happy to see our collaborative paper published in Nature Reviews Nephrology ben sprangers David Leaf #camilo porta and #markperazella Vall d'Hebron Institut de Recerca Vall d'Hebron

🎙️ #OLIC_app ALERT! Super excited to share the Onconephrotoxins Library Collection (OLIC) app. Our vision is to enable access to a comprehensive and fluid database of cutting edge cancer therapies American Society of Onconephrology #OLIC_app

Diagnosis and management of immune checkpoint inhibitor-associated #AKI. A new Review from ben sprangers, David Leaf, Camillo Porta, Maria Jose Soler and Mark Perazella go.nature.com/3SDiOEo

Immune checkpoint inhibitor associated AKI ca. 2022 from Nature Reviews Nephrology #Nephpearls 📌 #PathophysiologyPearls 📌 Diagnosis and management 📌 Rechallenge 👉🏼 pubmed.ncbi.nlm.nih.gov/36168055/

The power of biobanking native kidney biopsies #ASN2022.Dries Deleersnijder tells us.

Pseudo acute kidney injury associated with targeted anti-cancer agents – the truth is in the eye of the filtration marker | ⁦CKJ⁩ academic.oup.com/ckj/advance-ar…

🆕Editorial: Pseudo-AKI associated with targeted anti-cancer agents: the truth is in the eye of the filtration marker bit.ly/3R1gDuh 📸Proposed algorithm for elevated SCr levels in patients treated with targeted agents with known or anticipated potential for pseudo-AKI

1/8 PREPRINT ALERT🎙️What are the clinical consequences to discrepancies between serum creatinine and cystatin C based eGFR in patients with cancer? #TeamSise answers this very question @MGH_kidneys @Meg_Sise Paul E. Hanna, MD MSc Emma Qiyu Wang medrxiv.org/content/10.110…

Pathophysiology of immune checkpoint inhibitor-associated acute kidney injury. go.nature.com/3SDiOEo